gielnijpels: 2019

woensdag 6 november 2019

EASD

Amber van der Heijden heeft op de EASD de poster van ons gepresenteerd over de voorspellende waarde van de gemiddelde HbA1c waarde voor algehele sterfte. Het blijkt uit de data van ons cohort van mensen met type 2 diabetes dat de gemiddelde waarde veel beter sterfte voorspelt dan de actuele HbA1c waarde.

Brief Work History

Giel Nijpels (1949, Alkmaar, the Netherlands) studied medicine at the University of Amsterdam and specialised as a general practitioner. He worked in a health center in Hoorn ( a town about 50 km above Amsterdam) and in 1989 he was one of the initiators of the Hoorn Study, a study of glucose tolerance in the general population.

In 1996 is obtained a PhD at the VU Medical Center Amsterdam, this was a study of the Natural History of Impaired Glucose Tolerance, a part of the Hoorn Study.
He was granted a fellowship from the Dutch Diabetes Fund and he started his PhD research at the EMGO Institute at the Vrije Universiteit Amsterdam.

He obtained his PhD in Health Sciences in 1996. He started working as associate professor in diabetes research in 2002. In 2005 he was appointed professor of General Practice with special focus on diabetes care.

In 1996 he started the Diabetes Caresystem West-Friesland, one of the first diabetes management models in the Netherlands.

woensdag 6 november 2019

EASD

gielnijpels

Personal Information

Brief Work History

Links

Over mij

Blogarchief

Volgers

Giel Nijpels